Current status of intragastric balloon for obesity treatment

Abstract

Endoscopic bariatric therapy may be a useful alternative to pharmacological treatment for obesity, and it provides greater efficacy with lower risks than do conventional surgical procedures. Among the various endoscopic treatments for obesity, the intragastric balloon is associated with significant efficacy in body weight reduction and relief of comorbid disease symptoms. Anatomically, this treatment is based on gastric space-occupying effects that increase the feeling of satiety and may also affect gut neuroendocrine signaling. The simplicity of the intragastric balloon procedure may account for its widespread role in obesity treatment and its applicability to various degrees of obesity. However, advances in device properties and procedural techniques are still needed in order to improve its safety and cost-effectiveness. Furthermore, verification of the physiological outcomes of intragastric balloon treatment and the clinical predictive factors for treatment responses should be considered. In this article, we discuss the types, efficacy, safety, and future directions of intragastric balloon treatment.

Review article: Postoperative bariatric patients in the emergency department: Review of surgical complications for the emergency physician

“…With this procedure, an inflatable balloon is placed endoscopically in the stomach. The balloon facilitates weight loss by activating gastric stretch receptors producing a feeling of satiety, decreasing intragastric volume limiting food consumption, and delaying gastric emptying . A general recommendation for most IGBs is that they should be removed within 6 months of placement to reduce complications such as gastric ulceration .…”

“…A general recommendation for most IGBs is that they should be removed within 6 months of placement to reduce complications such as gastric ulceration . Patients with IGBs should also be placed on proton‐pump inhibitors during the first month post‐procedure to reduce the chance of gastric ulceration …”

Assessment of the Effect of Dietary Modifications and Bioenteric Intragastric Balloon Treatment on the Changes of Some Morphological and Biochemical Parameters in Obese Patients

“…It is very effective, non-invasive, totally reversible and the safest method among all bariatric procedures [54,55]. Endoscopic bariatric treatment may be an alternative to pharmacological treatment of obesity and provides higher efficiency with lower risk in comparison to conventional surgical procedures [56]. A very crucial element of the treatment of bariatric patients is the change of eating habits for the rest of patients' lives [57,58].…”

Analysis of effectiveness of life style modification as conservative methods of treatment in morbid obesity patients

“…Так, управління з контролю якості продуктів харчування та лікарських засобів СШа (FDA, 2016) схвалило 5 препаратів для лікування ожиріння, а саме орлістат, лоркасерин, фентермін/топірамат, налтрексон/бупропіон, ліраглутид [10]. відомий ефект використання ендоскопічних методик, насамперед, встановлення внутрішньошлункового балону [9] та баріатричної хірургії, насамперед, шлункового шунтування, рукавної резекції та бандажування шлунку [7]. З нефармакологічних підходів в комплексній консервативній терапії таких хворих розглядають модифікацію способу життя -поєднання дієти, фізичного навантаження та поведінкової терапії.…”